Successful treatments in multiple fields
Our product portfolio encompasses the following therapeutic areas: oncology, kidney diseases, hematology, bone diseases, cardiovascular diseases and inflammatory diseases
Amgen strives to deliver successful treatments to patients. This goes well beyond the development of innovative medicines and preventive therapies. We provide services, advice and new solutions that contribute to a better and more efficient healthcare system. We do this in the following fields:
Oncology and hematology
- Particular types of cancer involving tumor formation, such as breast cancer, colorectal cancer, prostate cancer, skin cancer
- Hematological types of cancer (cancers of particular blood cells) such as Acute Lymphoblastic Leukemia (ALL) and Multiple Myeloma (MM)
- Immune Mediated Trombocytopenia (ITP) - a disease whereby the immune system destroys the body’s own platelets
- A shortage of white or red blood cells due to chemotherapy
Kidney diseases
- Severe renal failure in the predialysis or dialysis stage
Bone diseases
- Osteoporosis - in post-menopausal women and also in men
- Bonecomplications caused by bonelesions or bonemetastases (dissemination of cancer in the bone) in patients with advanced cancer.
Cardiovascular diseases
- Elevated LDL cholesterol (the bad cholesterol) in patients with a very high risk of cardiovascular diseases, for whom currently available drugs have not yet succeeded in lowering the LDL cholesterol level sufficiently
Inflammatory diseases
- Rheumatic diseases such as rheumatoid arthritis
- Bowel disorders such as Crohn's disease and Colitis Ulcerosa
- Skin diseases such as psoriasis
- Eye diseases such as uveitis